Cologuard - j.b5z.net

Cologuard - j.b5z.net

Cologuard Where It Fits In Cologuard Screening test for colorectal cancer FIT-DNA : composite

of tests :(1) hemoglobin (2) molecular assays for DNA mutations (3) methylation biomarkers Colorectal

Neoplasms DNA shed into stool may reveal genetic mutations (KRAS) and epigenetic changes Test Procedure

Patient collects a stool sample in a special collection kit No dietary or medication restrictions Kit mailed back in 72 hours or less Repeat testing every 3 years (if negative) If positive, refer for colonoscopy Who is a Candidate?

Average risk patients Should not be used if: (1) history of colonic adenomas or cancer (2) history of IBD (3) family history of colon cancer/ Lynch Syndrome/FAP

Effectiveness Sensitivity (confirmed by colonoscopy) for CRC 92% Not affected by CRC stage or location of lesion Specificity for CRC was 87% Significance of a (+) Cologuard followed by a (-) colonoscopy is unknown

Colonoscopy Gold Standard-but not a perfect test prep needed and complications possible Miss rate of 2%

with large adenomas (>10mm), 25% <5 mm Positive Cologuard Changes screening colonoscopy to

diagnostic colonoscopy Proton Pump Inhibitors Potential Risks of PPIs Proton pump inhibitors have been

used on millions of patients since Prilosec was introduced in the USA in 1989 PPIs Changed GI Medicine

Mechanism of Action Binds to the H-KATPase on the luminal surface of the parietal cell Most effective after a prolonged fast and when the parietal

cell is stimulated after a meal Clinical Uses GERD-especially erosive esophagitis Peptic ulcer disease Eradication of H.

pylori Zollinger-Ellison syndrome Prevention NSAID ulcers Potential Adverse Effects

Increased risk of Clostridium difficile infection Calcium malabsorption and fracture risk Pneumonia Dementia Death Kidney Disease and PPIs

PPIs can cause acute interstitial nephritis Weak association with PPIs and chronic kidney disease (CKD)

Potential Malabsorption Iron malabsorption Magnesium malabsorption Vitamin B12 malabsorption Why Use PPIs

Inhibit gastric acid secretion much more effectively than H2 RAs Once-daily dosing decreases gastric acid secretion by 66%

Shortest Duration/< Dose Any Clinical Difference? rabeprazole omeprazole esomeprazole

lansoprazole pantoprazole PPIs and H2 Blockers H2RAs suppress acid much less effectively, but work more quickly-better

for prn use Taking them at the same time renders the PPI less effective

Recently Viewed Presentations

  • Business Dynamics Statistics JAVIER MIRANDA Center for Economic

    Business Dynamics Statistics JAVIER MIRANDA Center for Economic

    Business Dynamics Statistics JAVIER MIRANDA Center for Economic Studies US Census Bureau NJSDC June 2, 2009 Background Business dynamics are a fundamental part of Innovation Productivity Growth Job Creation Measuring business dynamics in official statistics is relatively new, but critical...
  • June 12 th 2016 Prelude for  Worship Martha

    June 12 th 2016 Prelude for Worship Martha

    20And the exiles of this host of the sons of Israel, Who are among the Canaanites as far as Zarephath, And the exiles of Jerusalem who are in Sepharad Will possess the cities of the Negev. 21The deliverers will ascend...
  • Introduction to Business & Marketing CAREER PLANNING Objectives

    Introduction to Business & Marketing CAREER PLANNING Objectives

    What is a career? Work history of one or more jobs in the same or related fields of interest. Each occupation builds on interest, knowledge, training, and experience from other jobs
  • Jurassic Park Notes  Shot  From when the camera

    Jurassic Park Notes Shot From when the camera

    Cacophony. A big noise. ... "Cut-to" moment. A moment where an important point is made, then the movie cuts to an example of that very point ("…Unless they (raptors) learn how to open doors - cut to: raptor opening a...
  • mSCOA Reporting Pack - Microsoft

    mSCOA Reporting Pack - Microsoft

    mSCOA tables for release subsequent to the technical review. is an important land mark in the project development life cycle. Locking down the chart, path the way for . finalising the review, revision and update. of the set of reports...
  • PACE Global Emerging Market Vehicle Project Final Report

    PACE Global Emerging Market Vehicle Project Final Report

    PACE Global Emerging Market Vehicle Project Final Report - July, 21st 2009 Design Process: Domain Knowledge and Client Requirements Functions and Interactions Conceptualization Evaluation and Selection Detail Design Analysis Motion Structural Drawings Product Knowledge obtained from Delphi experts Client Requirements...
  • 3rd Workshop on Affective and Attitude User Modeling

    3rd Workshop on Affective and Attitude User Modeling

    Co-Chairs: Cristina Conati, Eva Hudlicka, Christine Lisetti Objectives Explore core issues in expanding user models to include information of affect and attitudes: Detection Modeling Adaptation Validation and Evaluation ... across a range of applications Focus Questions Can we begin to...
  • 6. Técnicas de Acesso ao Meio - Páginas Pessoais - UTFPR

    6. Técnicas de Acesso ao Meio - Páginas Pessoais - UTFPR

    Gebauer & Griller GEMÜ Gossen-Metrawatt Hans Bernstein Harting Hilscher Hörbiger-Origa Idec Izumi Corp. ifm electronic IMI Norgren Limited IMI Norgren-Herion Fluidtronic Institut für Informationstechnik im J. Auer K. A. Schmersal Karl Lumberg Kuhnke Lachmann & Rink Leuze electronic Mitsubishi Electric...